Gastrointestinal Mucormycosis Presenting as Emphysematous Gastritis After Stem Cell Transplant for Myeloma

Mayo Clin Proc. 2020 Jan;95(1):33-34. doi: 10.1016/j.mayocp.2019.10.037.

Authors

Adam Buckholz¹, Alyson Kaplan²

Affiliations

¹ Department of Internal Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY. Electronic address: [email protected].
² Department of Internal Medicine, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY.

PMID: 31902426
DOI: 10.1016/j.mayocp.2019.10.037

No abstract available

Publication types

Case Reports

MeSH terms

Amphotericin B / administration & dosage*
Antifungal Agents / administration & dosage
Emphysema* / diagnosis
Emphysema* / etiology
Fatal Outcome
Gastrectomy / methods*
Gastritis* / diagnostic imaging
Gastritis* / etiology
Gastroscopy / methods*
Hematopoietic Stem Cell Transplantation / adverse effects
Hematopoietic Stem Cell Transplantation / methods
Humans
Immunocompromised Host
Male
Middle Aged
Mucormycosis* / diagnosis
Mucormycosis* / etiology
Mucormycosis* / therapy
Multiple Myeloma / pathology
Multiple Myeloma / surgery
Stomach / diagnostic imaging
Stomach / microbiology
Stomach / surgery
Tomography, X-Ray Computed / methods*

Substances

Antifungal Agents
Amphotericin B